Thanks to a focus on productivity and cost reduction within the pharmaceutical industry, along with a prevalence of Six Sigma-inspired improvement efforts, metrics are on a lot of people’s minds. Most, if not all, managers of R&D departments recognize the criticality of collecting data and tracking the performance of their many processes. However, many of these efforts are disjointed, inefficient, and misguided.
Conflicting reports, duplications of effort, and misapplied metrics plague many companies’ attempts at making sound data-driven business decisions. The creation of a central metrics group can go a long way towards eliminating wasted effort and drastically increasing the value of an organization’s data.
Fill out the form below to get our white paper.